In this video, Diana Abbott, PhD, and Grace Bosma, MS, discuss their team’s study on the outcomes and intensity of first-line therapy for the treatment of diffuse large B-cell lymphoma (DLBCL) in elderly...
In this podcast, Nirmish Shah, MD, discusses using machine learning and leveraging data analysis to make patient predictions about pain and readmission, to use interventions to minimize complications. Dr...
In this podcast, Pinkal Desai, MD, discusses the impact of previous chemotherapy and/or radiation exposure in patients who go on to develop acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS),...
In this podcast, Nirmish Shah, MD, discusses patient involvement and the use of patient-reported outcomes in the development of sickle cell disease interventions. Dr Shah’s team presented research on this...
In this podcast, Nirmish Shah, MD, discusses an overview, the results, and the preclinical and clinical impact of the study titled Preclinical and Clinical Use of AB1, a DNMT1 Protein Depleter, to...
Lead study author Lana Mucalo, MD, discusses her team’s study examining the prevalence of opioid-related mortality in patients with sickle cell disease from 2013 to 2019. She presented her research at the...
In this podcast, Santosh L Saraf, MD, discusses the decline of estimated glomerular filtration rate in patients with sickle cell disease as an indicator of kidney disease progression. Dr Saraf presented on...
In this podcast, Nirmish Shah, MD, speaks about real-world experience of voxelotor for the management of complications in sickle cell disease, including if voxelator helps improve hemoglobin. He also...
